AMZN
Amazon.com, Inc.
AMZN offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
HAS
Hasbro, Inc.
HAS has the edge over AMZN overall, supported by stronger fundamentals and stronger valuation.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
HAS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Healthy |
HAS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over HAS in the historical PE scenario, which offers more potential upside but is not a forecast.
HAS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $121 | — |
| Forward | 18x | $121 | — |
| Cheap | 20x | $133 | +9.6% |
| Fair | 29x | $198 | +63% |
| Expensive | 37x | $247 | +104% |
Historical ranges are pointers, not guarantees.
HAS's PE is in its cheap range at 18.0x. On analysts' estimates for next year's earnings, today's price would be 17.7x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
HAS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
HAS has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over HAS on earnings, with more consistent year-over-year improvement.
HAS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.85 | +1.7% |
| Q3 2026 | $6.74 | +$10.75 |
| Q2 2026 | $5.61 | +$9.67 |
| Q1 2026 | -$1.61 | -153% |
| Q4 2025 | -$2.30 | -184% |
| Q3 2025 | -$4.01 | +$0.64 |
| Q2 2025 | -$4.06 | +$3.41 |
| Q1 2025 | $3.03 | +$13.18 |
| Q4 2024 | $2.75 | +$13.48 |
HAS has returned to profit: it earned $6.74 per share over the past year, after losing money the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
HAS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +0.3% |
| Q2 2026 | $1.3B | +14% |
| Q1 2026 | $1.1B | +11% |
| Q4 2025 | $1.6B | -4.5% |
| Q3 2025 | $1.6B | +24% |
| Q2 2025 | $1.1B | +14% |
| Q1 2025 | $1B | +33% |
| Q4 2024 | $1.7B | +33% |
HAS's revenue fell from its 2021 peak and has held roughly level since: $1.6B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | +11 points |
| Q2 2026 | 20% | +90 points |
| Q1 2026 | 24% | +7.3 points |
| Q4 2025 | 18% | +15 points |
| Q3 2025 | 21% | -2.1 points |
| Q2 2025 | -70% | -92 points |
| Q1 2025 | 17% | +1.6 points |
| Q4 2024 | 3.5% | +97 points |
HAS has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
HAS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $273.4M | +4.8% |
| Q2 2026 | $247.7M | +349% |
| Q1 2026 | $315.5M | +154% |
| Q4 2025 | $389.5M | +22% |
| Q3 2025 | $260.9M | +50% |
| Q2 2025 | $55.2M | -59% |
| Q1 2025 | $124.3M | -5.8% |
| Q4 2024 | $318.8M | -6.7% |
HAS has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
HAS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -600K shares |
| 1 year | +0.2% | +300K shares |
| 3 years | +2.7% | +3.7M shares |
| 5 years | +2.9% | +4M shares |
| Available history | +11% | +14M shares |
HAS has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $107.8M |
| Q2 2026 | $33.8M |
| Q1 2026 | $7.7M |
| Q4 2023 | — |
| Q3 2023 | — |
| Q4 2022 | — |
| Q3 2022 | $1M |
| Q4 2020 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over HAS on leverage, with a lower net debt burden relative to earnings.
HAS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.8x | Healthy |
| Q2 2026 | 2.1x | Moderate |
| Q1 2026 | 11.5x | High |
| Q4 2025 | 17.0x | High |
| Q1 2025 | 3.0x | Elevated |
| Q4 2024 | 3.2x | Elevated |
| Q2 2023 | 31.9x | High |
| Q1 2023 | 6.6x | High |
HAS's net debt is about 1.8 years of its operating earnings (EBITDA), down from 3.0 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
HAS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 77.5 | Overbought |
| Stochastic | 91.1 | Overbought |
HAS's weekly RSI is 77 (overbought) and its Stochastic is 91 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
HAS PE vs Consumer Cyclical Sector
| Metric | HAS | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | Same PE |
| PE % | 10 | 47 | 37 pts below |
HAS has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
HAS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $105.8 | 15% above |
| 20 week MA | $96.0 | 27% above |
| 50 week MA | $92.4 | 31% above |
| 100 week MA | $80.4 | 51% above |
| 200 week MA | $69.7 | 74% above |
HAS is in an uptrend: it's above all five of its weekly moving averages, and 74% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
HAS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $105.8 | $93.2 | -12% |
| 2021 | $93.2 | $97.9 | +5.1% |
| 2022 | $97.9 | $58.2 | -41% |
| 2023 | $58.2 | $51.1 | -12% |
| 2024 | $51.1 | $56.7 | +11% |
| 2025 | $56.7 | $82.6 | +46% |
| 2026 YTD | $82.6 | $121.5 | +47% |
HAS has the edge over AMZN on returns for 2026, with the stronger performance.